Eaton Corporation plc vs Humana Inc — how do they compare? Eaton Corporation plc trades at $429.64 (market cap $164.88B), while Humana Inc trades at $434.95 (market cap $46.49B). The key difference: Eaton Corporation plc is far larger — about 3.5× Humana Inc's market cap, and Eaton Corporation plc pays the higher dividend (1.04%). Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and Humana Inc for 53 Days on average.
| ETN | HUM | |
|---|---|---|
Market Cap | $164.88B | $46.49B |
Volume | 2,535,086 | 2,567,704 |
Sector | Industrials | Health |
52-Week High | $459.96 | $409.85 |
52-Week Low | $315.82 | $163.67 |
Typical Hold Time | 31 Days | 53 Days |
Enterprise Value | $185.51B | $53.84B |
Dividend Yield | 1.04% | 0.91% |
Signals from Pluang's Aura AI — not financial advice
Eaton Corporation (ETN) trades at $424.64, down 1.55% today, with a bearish technical signal despite strong fundamentals. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. ETN maintains robust profitability with 12.75% net income margin and 19.71% ROE, supported by strategic acquisitions in data center and aerospace markets. Recent news highlights growing investor attention and positive analyst coverage.
ETN presents a compelling growth story driven by data center demand and grid modernization, with 70% analyst buy ratings and a $502.38 consensus price target suggesting 18% upside. However, elevated valuation multiples (P/E 43.23) and bearish technical indicators warrant caution. Key risks include execution of acquisition strategy and competitive pressures in the electronics manufacturing sector.
Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.
The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →